Gomma, AH and Elrayess, MA and Knight, CJ and Hawe, E and Fox, KM and Humphries, SE (2002) The endothelial nitric oxide synthase (Glu298Asp and-786T > C) gene polymorphisms are associated with coronary in-stent restenosis. EUR HEART J , 23 (24) 1955 - 1962. 10.1053/euhj.2002.3400.
Full text not available from this repository.
Aims Coronary stent deployment is a major advance in percutaneous treatment of ischaemic heart disease, but 10-40% of patients still develop angiographic restenosis by 6 months due to neointimal hyperplasia. Patient-specific factors, including genetic factors, can contribute to this process. We have conducted a prospective study to examine the involvement of genetic risk factors (eNOS, ACE, MMP-3, IL-6, and PECAM-1) in restenosis following coronary stent deployment. showed a higher frequency of restenosis with an odds ratio of 1(.)88 (95%CI: 1(.)01-3(.)51, P=0(.)043) compared to 298Glu homozygotes. Carriers of the -786C allele of the eNOS -786T>C polymorphism also showed a higher frequency of restenosis with odds ratio of 2(.)06 (95%CI: 1(.)08-3(.)94, P=0(.)028). These effects were essentially additive and were independent of other classical risk factors. Other studied genes did not show significant association with coronary in-stent restenosis.Methods and Results A total of 226 patients who underwent elective and successful coronary artery stenting to de novo lesions in native coronary arteries were studied. Two hundred and five (90(.)7%) patients were restudied by coronary angiogram at 6 months and the stented lesions were assessed using an automated quantitative angiography system. Genotype was determined by polymerase chain reaction (PCR) and restriction enzyme digestion. Restenosis rate, defined as greater than or equal to50% diameter stenosis, was 29(.)3%. The overall genotype frequency distributions were in Hardy-Weinberg equilibrium for all variants. Carriers of the 298Asp allele of the eNOS Glu298Asp polymorphismConclusion In patients with coronary artery disease, the possession of the 298Asp and -786C variants of the eNOS gene are a risk factor for coronary in-stent restenosis, demonstrating the importance of the nitric oxide system in restenosis. (C) 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved.
|Title:||The endothelial nitric oxide synthase (Glu298Asp and-786T > C) gene polymorphisms are associated with coronary in-stent restenosis|
|Keywords:||eNOS polymorphism, restenosis, stents, genes, angiography, MAJOR RISK FACTOR, ARTERY DISEASE, CONVERTING-ENZYME, BALLOON ANGIOPLASTY, INSERTION/DELETION POLYMORPHISM, DIRECTIONAL ATHERECTOMY, BLOOD-PRESSURE, HEART-DISEASE, PROMOTER, PLASMA|
|UCL classification:||UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science|
Archive Staff Only: edit this record